Our publications

This publication provides valuable insights into the impact of daily low-dose aspirin on the incidence of type 2 diabetes in healthy older adults, using data from the ASPREE randomised trial.

This publication explores the association between socioeconomic status and the incidence, quality-of-care metrics, and outcomes for patients with cardiogenic shock in a pre-hospital setting. Its findings highlight the importance of addressing socioeconomic disparities to improve the care and outcomes of high-risk patients in emergency medical settings.

This publication emphasises the value of pragmatic randomised controlled trials in real-world settings, aiming to improve the external validity and applicability of clinical research. Through the PRIME-9 initiative, it fosters international collaboration, enhancing the ability to address global health challenges. FWCI: 14.85.

This publication is impactful as it investigates the prevalence and clinical outcomes of patients with SMuRF-less acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). By analysing real-world patient data, the study highlights potential gaps in risk stratification and treatment approaches for individuals who experience ACS without traditional risk factors.

This publication sheds light on the significant impact of the COVID-19 pandemic on out-of-hospital cardiac arrest outcomes, using individual patient data for a comprehensive analysis. Its findings are essential for understanding the broader implications of COVID-19 on emergency medical services. FWCI: 10.63.

This study evaluates the use of prehospital point-of-care troponin testing combined with paramedic risk assessment to improve chest pain management and early diagnosis of acute coronary syndromes. Its findings have the potential to enhance emergency care efficiency, reduce hospital admissions, and improve patient outcomes. Read more about the clinical trial led by Professor Dion Stub and Dr Jocasta Ball.

This study examined how changes in body size over time affect all-cause and cause-specific mortality in healthy older adults, providing critical insights into aging and health outcomes. Citations: 26, FWCI: 8.96.

This publication provides a methodological perspective on registry-based randomised trials, highlighting their potential to generate high-quality, real-world evidence with greater efficiency and potential to enhance clinical research.
FWCI: 6.20.

This study showcases how a smartphone-based application can improve the speed and reliability of patient enrolment and randomisation in pre-hospital clinical trials. It highlights the potential for digital innovation to enhance emergency medical research, leading to more efficient and effective patient care.
FWCI: 7.63.

This study highlights the importance of integrated care in cardiovascular disease management, emphasising a multidisciplinary approach to improving patient outcomes. Its recommendations help shape best practices, improving the quality of care and patient outcomes in cardiovascular nursing and allied professions.
Citations: 23, FWCI: 9.18.

This publication highlights grave clinical implications of systems issues in ambulance and emergency departments, leading to ramping and its association with poorer outcomes and mortality.

The objective was to investigate the effect of aspirin cessation versus continuation on disability-free survival and other clinical outcomes in a post hoc analysis of ASPREE participants who were regularly taking aspirin before trial enrolment.

This publication establishes rationale introducing novel treatment strategies laying foundation for future studies.

This is a large population-based study looking into compliance trajectories of statins in the general population. The study highlighted the need for ongoing research and new interventions to understand and mitigate the factors contributing to medication non-adherence and discontinuation which is currently underway.

This world first study provided data and experiences of the swift transition of cardiac rehabilitation programs to telehealth during the COVID19 pandemic. This paper has >1200 downloads and is cited by the Canadian Agency for Drugs and Technologies in Health (2022) in a policy insight document.

One of the first studies to carefully review national cardiac registries, identifying key characteristics and opportunities for international collaboration of these invaluable resources.

The first trial worldwide of non-opioid use in cardiac intervention analgesia. It provided a framework and clinical rationale for the seminal AVOID 2 ambulance trial. PhD candidate and first author Dr Hima Fernando was awarded the prestigious Ralph Reader award 2021 for this work. (4 CITES (Scopus), FWCI=1.95). Read our lay summary on the Monash Faculty of Medicine, Nursing and Health Sciences newsfeed.

The findings from this landmark trial have demonstrated that the poly-pill approach to blood pressure and lipid lowering improves long–term outcomes with the combined benefits of blood pressure and lipid lowering in moderate risk individuals. (Citations 5 (92nd percentile); FWCI – 3.31)

This paper illustrates the importance of gender disparities in cardiovascular disease management of acute cardiac care, now the focus of major national initiatives to bridge the gap.

These findings have demonstrated the safety and efficacy of a “quad-pill approach” to blood pressure lowering that produces highly significant reductions that increase the opportunity for global improvements in the prevention of cardiovascular disease. (Citations 5 (92nd percentile); FWCI = 3.31)